RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD)
CUSIP: 75955J402
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock ($.001 par value)
- Shares outstanding
- 74,702,121
- Total 13F shares
- 5,303,151
- Share change
- -916,357
- Total reported value
- $3,177,608
- Price per share
- $0.60
- Number of holders
- 48
- Value change
- -$311,761
- Number of buys
- 16
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 75955J402?
CUSIP 75955J402 identifies RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75955J402:
Top shareholders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.6%
|
1,227,928
|
$329,000 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
1,208,075
|
$326,180 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.76%
|
566,905
|
$153,064 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.66%
|
495,146
|
$133,689 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.4%
|
301,883
|
$81,529 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.39%
|
288,000
|
$77,760 | — | 31 Mar 2025 | |
| AdvisorShares Investments LLC |
13F
|
Company |
0.37%
|
276,514
|
$75,654 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.3%
|
224,846
|
$60,708 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.23%
|
170,544
|
$46,047 | — | 31 Mar 2025 | |
| PARSONS CAPITAL MANAGEMENT INC/RI |
13F
|
Company |
0.22%
|
163,336
|
$44,101 | — | 31 Mar 2025 | |
| RBF Capital, LLC |
13F
|
Company |
0.22%
|
163,261
|
$44,080 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.19%
|
144,789
|
$39,094 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
124,100
|
$33,507 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.16%
|
120,852
|
$32,630 | — | 31 Mar 2025 | |
| Cedric O'Gorman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
10,121
|
$32,185 | — | 23 May 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
106,735
|
$28,818 | — | 31 Mar 2025 | |
| MGO ONE SEVEN LLC |
13F
|
Company |
0.13%
|
100,000
|
$27,000 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
59,571
|
$16,084 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.07%
|
52,043
|
$14,000 | — | 31 Mar 2025 | |
| apricus wealth, LLC |
13F
|
Company |
0.07%
|
48,962
|
$13,220 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.06%
|
42,797
|
$11,555 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.05%
|
40,270
|
$10,873 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.05%
|
36,230
|
$9,782 | — | 31 Mar 2025 | |
| AlTi Global, Inc. |
13F
|
Company |
0.04%
|
31,975
|
$8,634 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
28,641
|
$7,733 | — | 31 Mar 2025 | |
| WEALTHEDGE INVESTMENT ADVISORS, LLC |
13F
|
Company |
0.04%
|
28,000
|
$7,560 | — | 31 Mar 2025 | |
| Robertson Stephens Wealth Management, LLC |
13F
|
Company |
0.03%
|
25,000
|
$6,750 | — | 31 Mar 2025 | |
| Tortoise Investment Management, LLC |
13F
|
Company |
0.03%
|
21,676
|
$5,853 | — | 31 Mar 2025 | |
| World Investment Advisors |
13F
|
Company |
0.03%
|
21,644
|
$5,844 | — | 31 Mar 2025 | |
| Pandora Wealth, Inc. |
13F
|
Company |
0.03%
|
20,000
|
$5,400 | — | 31 Mar 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
14,012
|
$3,783 | — | 31 Mar 2025 | |
| Lido Advisors, LLC |
13F
|
Company |
0.02%
|
13,905
|
$3,754 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
13,716
|
$3,703 | — | 31 Mar 2025 | |
| StoneX Group Inc. |
13F
|
Company |
0.02%
|
13,234
|
$3,573 | — | 31 Mar 2025 | |
| Bedel Financial Consulting, Inc. |
13F
|
Company |
0.01%
|
10,000
|
$3,572 | — | 31 Mar 2025 | |
| Hexagon Capital Partners LLC |
13F
|
Company |
0.01%
|
4,000
|
$1,080 | — | 31 Mar 2025 | |
| American Capital Advisory, LLC |
13F
|
Company |
0.01%
|
3,908
|
$1,056 | — | 31 Mar 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
4,482
|
$1,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,168
|
$585 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
158
|
$43 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
102
|
$28 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
72
|
$19 | — | 31 Mar 2025 | |
| Front Row Advisors LLC |
13F
|
Company |
0%
|
6
|
$2 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
5
|
$1 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2
|
$1 | — | 31 Mar 2025 | |
| Eric Thomas Schmidt |
3/4/5
|
Director |
—
class O/S missing
|
150,000
|
— | — | 25 May 2023 |
Institutional Holders of RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) as of Q2 2025
As of 30 Jun 2025,
RELMADA THERAPEUTICS, INC. - Common Stock ($.001 par value) (RLMD) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,303,151 shares.
The largest 10 holders included
Driehaus Capital Management LLC, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., AdvisorShares Investments LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, DEUTSCHE BANK AG\, Corient Private Wealth LLC, UBS Group AG, and PARSONS CAPITAL MANAGEMENT INC/RI.
This page lists
48
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
43
Q2 2025 holders
48
Holder diff
5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.